Molecular and Cellular Pharmacology, Vol 10, No 3 (2018)

FDA Approves New Drug to Treat Travelers’ Diarrhea

Abstract

The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers’ diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the….

Full Text: PDF